Literature DB >> 23028047

Transcriptional regulation of the human tumor suppressor DOK1 by E2F1.

Maha Siouda1, Jiping Yue, Ruchi Shukla, Sophie Guillermier, Zdenko Herceg, Marion Creveaux, Rosita Accardi, Massimo Tommasino, Bakary S Sylla.   

Abstract

The expression of the tumor suppressor DOK1 is repressed in a variety of human tumors as a result of hypermethylation of its promoter region. However, the molecular mechanisms by which DOK1 expression is regulated have been poorly investigated. Here, we show that the expression of DOK1 is regulated mainly by the transcription factor E2F1. We identified three putative E2F1 response elements (EREs) in the DOK1 promoter region. E2F1 had a relatively higher binding affinity for the ERE located between bp -498 and -486 compared with the other two EREs. E2F1 gene silencing strongly inhibited DOK1 expression. E2F1-driven DOK1 transcription occurred in the presence of cellular stresses, such as accumulation of DNA damage induced by etoposide. DOK1 silencing promoted cell proliferation and protected against etoposide-induced apoptosis, indicating that DOK1 acts as a key mediator of cellular stress-induced cell death. Most importantly, we observed that DNA methylation of the DOK1 core promoter region found in head and neck cancer cell lines hampered the recruitment of E2F1 to the DOK1 promoter and compromised DOK1 expression. In summary, our data show that E2F1 is a key factor in DOK1 expression and provide novel insights into the regulation of these events in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23028047      PMCID: PMC3497605          DOI: 10.1128/MCB.01050-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

Review 1.  DNA methylation patterns and epigenetic memory.

Authors:  Adrian Bird
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

2.  Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation.

Authors:  W C Lin; F T Lin; J R Nevins
Journal:  Genes Dev       Date:  2001-07-15       Impact factor: 11.361

3.  The identification of E2F1-specific target genes.

Authors:  Julie Wells; Carrie R Graveel; Stephanie M Bartley; Steven J Madore; Peggy J Farnham
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation.

Authors:  Julie Wells; Peggy J Farnham
Journal:  Methods       Date:  2002-01       Impact factor: 3.608

5.  Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers.

Authors:  Jiyeon Yun; Sang-Hyun Song; Jinah Park; Hwang-Phill Kim; Young-Kwang Yoon; Kyung-Hun Lee; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang; Tae-You Kim
Journal:  Lab Invest       Date:  2012-04-16       Impact factor: 5.662

6.  The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c.

Authors:  Natalie O Karpinich; Marco Tafani; Ronald J Rothman; Matteo A Russo; John L Farber
Journal:  J Biol Chem       Date:  2002-02-25       Impact factor: 5.157

7.  The rasGAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors.

Authors:  Norio Yamakawa; Kunihiro Tsuchida; Hiromu Sugino
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

8.  Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia.

Authors:  Sanghoon Lee; François Roy; Carlos M Galmarini; Rosita Accardi; Jocelyne Michelon; Alexandra Viller; Emeline Cros; Charles Dumontet; Bakary S Sylla
Journal:  Oncogene       Date:  2004-03-25       Impact factor: 9.867

9.  Etoposide upregulates Bax-enhancing tumour necrosis factor-related apoptosis inducing ligand-mediated apoptosis in the human hepatocellular carcinoma cell line QGY-7703.

Authors:  Lin Miao; Peng Yi; Yi Wang; Mian Wu
Journal:  Eur J Biochem       Date:  2003-07

10.  p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).

Authors:  A Di Cristofano; M Niki; M Zhao; F G Karnell; B Clarkson; W S Pear; L Van Aelst; P P Pandolfi
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

View more
  10 in total

1.  lncRNA-HIT promotes cell proliferation of non-small cell lung cancer by association with E2F1.

Authors:  L Yu; F Fang; S Lu; X Li; Y Yang; Z Wang
Journal:  Cancer Gene Ther       Date:  2017-04-21       Impact factor: 5.987

2.  Dimeric switch of Hakai-truncated monomers during substrate recognition: insights from solution studies and NMR structure.

Authors:  Manjeet Mukherjee; Fan Jing-Song; Sarath Ramachandran; Graeme R Guy; J Sivaraman
Journal:  J Biol Chem       Date:  2014-07-29       Impact factor: 5.157

3.  mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes.

Authors:  Judong Luo; Wenjie Wang; Yiting Tang; Dandan Zhou; Yi Gao; Qi Zhang; Xifa Zhou; Hui Zhu; Ligang Xing; Jinming Yu
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207

4.  Disease-related cellular protein networks differentially affected under different EGFR mutations in lung adenocarcinoma.

Authors:  Toshihide Nishimura; Haruhiko Nakamura; Ayako Yachie; Takeshi Hase; Kiyonaga Fujii; Hirotaka Koizumi; Saeko Naruki; Masayuki Takagi; Yukiko Matsuoka; Naoki Furuya; Harubumi Kato; Hisashi Saji
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

5.  Comprehensive analysis of DOK family genes expression, immune characteristics, and drug sensitivity in human tumors.

Authors:  Yongjun Guan; Man Li; Zhendong Qiu; Junhui Xu; Yichao Zhang; Ning Hu; Xuanzhe Zhang; Wenyi Guo; Jingping Yuan; Qiao Shi; Weixing Wang
Journal:  J Adv Res       Date:  2021-06-12       Impact factor: 10.479

6.  Docking protein 1 and free fatty acids are associated with insulin resistance in patients with type 2 diabetes mellitus.

Authors:  Xiaoqin Ha; Xiaoling Cai; Huizhe Cao; Jie Li; Bo Yang; Ruru Jiang; Xin Li; Bin Li; Yuan Xin
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

7.  BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.

Authors:  Sayem Miah; Raghuveera Kumar Goel; Chenlu Dai; Natasha Kalra; Erika Beaton-Brown; Edward T Bagu; Keith Bonham; Kiven E Lukong
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

8.  Epstein-Barr virus down-regulates tumor suppressor DOK1 expression.

Authors:  Maha Siouda; Cecilia Frecha; Rosita Accardi; Jiping Yue; Cyrille Cuenin; Henri Gruffat; Evelyne Manet; Zdenko Herceg; Bakary S Sylla; Massimo Tommasino
Journal:  PLoS Pathog       Date:  2014-05-08       Impact factor: 6.823

9.  EgoNet: identification of human disease ego-network modules.

Authors:  Rendong Yang; Yun Bai; Zhaohui Qin; Tianwei Yu
Journal:  BMC Genomics       Date:  2014-04-28       Impact factor: 3.969

10.  Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer.

Authors:  Teresa Friedrich; Michaela Söhn; Tobias Gutting; Klaus-Peter Janssen; Hans-Michael Behrens; Christoph Röcken; Matthias P A Ebert; Elke Burgermeister
Journal:  EBioMedicine       Date:  2016-05-05       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.